This report includes a dedicated chapter covering supply chain exposure, export controls, sanctions risk, and regulatory shifts affecting Infant Phototherapy Lamp Market.
Market Overview
Overview
Infant Phototherapy Lamps are used in medical treatments that involve exposure to fluorescent light bulbs, and blue light to treat certain medical conditions. Infant Phototherapy Lamps are mostly used for the treatment of babies born with Neonatal Jaundice. The rising prevalence of Neonatal Jaundice around the world is driving the growth of the Global Infant Phototherapy Lamp Market. Neonatal Jaundice affects 60% to 80% of newborn babies, is a leading cause of hospitalization in the first week of life and needs neonatal jaundice light therapy. Worldwide Neonatal hyperbilirubinaemia accounted for around 1309 deaths per 100,000 live births in 2025 and ranked seventh of neonatal deaths. However, the development of purpura, a bronze baby syndrome in infants, complications associated with photosensitive infants may restrict the growth of the infant phototherapy lamp market. However, phototherapy in newborns has seen tremendous technological advancements in the design and development of LED bulbs with longer life, energy-efficient which require less energy than conventional bulbs will drive the growth of the market in the forecast period.
Product types & Competitive analysis
On the basis of product types, the market is categorized into Light-emitting Diodes (LEDs), Fluorescence and UV. The Light-emitting Diodes (LEDs) segment accounted for the largest revenue share in 2025. The Light-emitting Diodes (LEDs) segment is expected to sustain its dominance over the forecast period owing to the increased use of Infant Phototherapy Lamps. Light-emitting Diodes (LEDs) can treat Neonatal Jaundice faster than any other phototherapy light, they have a comparatively longer life of 20 thousand hours with no emission of ultraviolet and infrared light. Fluorescent was the fastest-growing segment in 2022 and is expected to show considerable growth in the forecast period 2026-2032.
The competitive analysis included in the research study helps users to understand key players market positioning and marketing strategies. Treatment with blue light phototherapy is vital to avoid the ill effects of severe cases of neonatal jaundice. There are many types of phototherapy lamps which include LED, halogen lights, fluorescent blue lights, and phototherapy blankets. Several manufacturers in the industry are producing and improving their product portfolio to offer excellent performance and operational features to provide effective treatment to newborns born with Neonatal Jaundice. Several advancements are seen in creating new lamps with equal light distribution, thermal management, low power consumption, and low-cost production methods. In addition to this companies are also involved in mergers and acquisitions of potential players to increase their competitive advantage and presence across regions. Several small to medium-sized lamp manufacturers are arising in China and other Asian countries offering low-cost products to the global market.
Moreover, in January 2021 Electro-mechanical repair specialist RUBIX UK acquired Knowlton and Newman a company specialized in the repair and replacement of electric motors, pumps, and gearboxes, providing service to minimize downtime for customers and reduce costs. The acquisition of Knowlton and Newman will add to up southern regional hub of Rubix UK’s existing service centres in the Midlands, Southwest and North of England. Several players are working together and entering strategic collaborations and partnerships to offer new products and solutions to the industry.
Application & Regional analysis
Based on applications of Infant Phototherapy Lamps, the market is segmented into Hospitals and Neonatal Clinics. The Hospital segment accounted for the largest revenue share in 2025 and is anticipated to lead the market growth over the forecast period. The majority of Infant Phototherapy is performed at hospitals due to the presence of advanced equipment and professional experts. These facilities offer excellent support, promoting optimal outcomes and executing strategies for high-risk infants. In addition, the rising number of hospitals across the world, and growing investments in developing countries for healthcare infrastructure from the private and government sector will drive the growth of the segment in the forecast period. The neonatal clinic's segment was the fastest-growing segment in 2025 and is expected to witness significant growth in the forecast period.
The regional outlook of the research study is based on an analysis of the market in North America, Europe, Asia Pacific, Middle East, South America, Africa & Rest of the World. North America led the Global Infant Phototherapy Lamps Market accounting for the largest revenue share in 2025. The rising burden of Neonatal Jaundice, the presence of sophisticated healthcare facilities, and the faster adoption of new treatments and therapies are some key driving factors for the growth of the North American Infant Phototherapy Lamps Market. The U.S. was the largest market in North America in terms of revenue generation followed by Canada in 2025. Asia Pacific was the fastest-growing region and is expected to grow at the highest CAGR in the forecast period 2026-2032. The growth in Asia Pacific region was primarily driven by the growing prevalence of Neonatal Jaundice, the rise in the number of infant deaths, and a rapidly growing healthcare infrastructure.
The prevalence rate of Neonatal Jaundice varies from country to country and is generally found in South Asian countries such as India, Pakistan, Afghanistan, Nepal, Bangladesh, Bhutan, and Sri Lanka. In India, each year around 26 million children are born. The major causes of mortality include prematurity, low weight, pneumonia, asphyxia, congenital anomalies, and other disease-related deaths. Rising initiatives of private and government programs to raise awareness regarding neonatal and child health will supplement the growth of the Indian Infant Phototherapy Lamps Market in the forecast period 2026-2032. The European market is expected to grow at a significant rate owing to the increased incidence of Neonatal Jaundice and the presence of advanced healthcare facilities. Germany, the U.K., France, Italy, and Spain are the major contributors to the European Infant Phototherapy Lamps market. South America and the Middle East Africa region are expected to witness significant growth in the Infant Phototherapy Lamps Market owing to developing healthcare infrastructure and rising investments from the private and government sectors.
Infant Phototherapy Lamp Market : Product Types
- Light-emitting Diodes (LEDs)
- Fluorescence
- UV
Infant Phototherapy Lamp Market : Application
- Hospitals
- Neonatal Clinics
Infant Phototherapy Lamp Market : Competitive Analysis
The report includes accurate analysis of key players with Market Value, Company profile, and SWOT analysis. The Study consists of the following key players in the Global Infant Phototherapy Lamp Market :
- General Electric (GE Healthcare)
- Ibis Medical Equipment & Systems Pvt. Ltd
- Natus
- Ningbo David Medical
- Atom Medical Corporation
- Medela
Geographical analysis of Infant Phototherapy Lamp Market :
-
North America
- U.S.A
- Canada
- Europe
- France
- Germany
- Spain
- UK
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- South East Asia
- Latin America
- Brazil
- Middle East and Africa
Therapeutic Devices Landscape
Report Coverage
| Parameter | Details |
|---|---|
| Base Year | 2026 |
| Historical Data | 2020 – 2025 |
| Forecast Period | 2026 – 2032 |
| Regional Scope | North America · Europe · Asia-Pacific · Latin America · MEA · RoW |
Frequently Asked Questions
The Infant Phototherapy Lamp Market report considers 2026 as the base year, with historical data from 2020 to 2025 and forecasts covering 2026 to 2032.
The report covers historical data from 2020 to 2025 and provides forecasts through 2032, giving a complete historical-to-forecast view of the market.
The study covers North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, and Rest of World — with country-level breakdowns within each region.
Yes. The report includes detailed profiles of 8+ key companies covering financials, strategy, product portfolio, and recent developments.
Yes. A dedicated section covers geopolitical risk factors and their impact on supply chains, pricing dynamics, and regional demand patterns through 2032.